Exact Sciences Corp (NAS:EXAS)
$ 53.52 2.52 (4.94%) Market Cap: 9.88 Bil Enterprise Value: 11.78 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 78/100

Q4 2023 Exact Sciences Corp Earnings Call Transcript

Feb 21, 2024 / 10:00PM GMT
Release Date Price: $63.29 (+0.88%)
Operator

Good afternoon, and welcome to the Exact Sciences Fourth Quarter 2023 Earnings Call. Please be advised that this call will be recorded. (Operator Instructions) I would now like to turn the conference over to Mr. Nate Harrill, Vice President of Investor Relations. You may begin your conference.

Nathan Harrill

Thanks, Jeanie. Thank you for joining us for Exact Sciences' Fourth Quarter 2023 Conference Call. On the call today are Kevin Conroy, the company's Chairman and CEO; and Jeff Elliott, our Chief Financial Officer. Everett Cunningham, our Chief Commercial Officer; and Brian Baranick, our General Manager of Precision Oncology will also be available for questions.

Exact Sciences issued a news release earlier this afternoon detailing our fourth quarter financial results. This news release and today's presentation are available on our website at exactsciences.com. During today's call, we will make forward-looking statements based on current expectations. Our actual results may be materially different from such statements. Discussions of non-GAAP figures and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot